Alnylam Pharmaceuticals (ALNY) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free ALNY Stock Alerts $152.61 -1.78 (-1.15%) (As of 10:34 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAlnylam Pharmaceuticals (NASDAQ:ALNY) Receives "Outperform" Rating from BMO Capital Marketsamericanbankingnews.com - March 28 at 4:40 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Given "Outperform" Rating at BMO Capital Marketsmarketbeat.com - March 27 at 10:15 AMDecoding 12 Analyst Evaluations For Regeneron Pharmaceuticalsmarkets.businessinsider.com - March 26 at 11:11 AMBuy Rating Affirmed for Alnylam Pharmaceuticals on Strong Commercial Business and Expanding CNS Pipelinemarkets.businessinsider.com - March 25 at 7:27 PMStockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to "Buy"americanbankingnews.com - March 23 at 5:10 AMInvestors Purchase Large Volume of Alnylam Pharmaceuticals Call Options (NASDAQ:ALNY)americanbankingnews.com - March 23 at 1:03 AMStockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Buymarketbeat.com - March 22 at 11:10 PMAlnylam Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:ALNY)marketbeat.com - March 22 at 1:40 PMAlnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Sessionbusinesswire.com - March 20 at 8:00 AMRapport Therapeutics Appoints Pioneering Industry Leader John Maraganore to Board of Directorsfinance.yahoo.com - March 19 at 8:34 AMTD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA)markets.businessinsider.com - March 19 at 3:34 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by Vanguard Group Inc.marketbeat.com - March 17 at 5:28 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Deutsche Bank AGmarketbeat.com - March 15 at 5:46 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Downgraded by StockNews.com to Holdmarketbeat.com - March 14 at 11:10 PMWellington Management Group LLP Purchases 364,021 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - March 13 at 9:20 AMAlnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Diseasebusinesswire.com - March 13 at 7:30 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYprnewswire.com - March 11 at 7:30 PMBrokers Set Expectations for Alnylam Pharmaceuticals, Inc.'s FY2026 Earnings (NASDAQ:ALNY)marketbeat.com - March 11 at 3:23 AMIs Alnylam's HELIOS-B Delay A Red Flag?seekingalpha.com - March 10 at 12:54 AMTudor Investment Corp Et Al Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - March 9 at 10:36 AMAmeriprise Financial Inc. Buys 80,862 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - March 8 at 6:55 AMRoyal London Asset Management Ltd. Raises Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - March 7 at 9:27 AMAlnylam, Roche blood pressure drug scores in second mid-stage trialfinance.yahoo.com - March 6 at 4:45 PMAnalysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and IO Biotech (IOBT)markets.businessinsider.com - March 6 at 4:45 PMBuy Rating Affirmed for Alnylam Pharma as Zilebesiran Shows Blockbuster Potentialmarkets.businessinsider.com - March 6 at 4:45 PMAlnylam, Roche mark second Phase 2 win for blood pressure therapymsn.com - March 5 at 1:38 PMAlnylam Pharmaceuticals' (ALNY) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 5 at 1:14 PMRoche, Alnylam say blood pressure drug succeeds in mid-stage trialfinance.yahoo.com - March 5 at 8:37 AMAlnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensivesbusinesswire.com - March 5 at 7:30 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by Schonfeld Strategic Advisors LLCmarketbeat.com - March 4 at 7:51 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYprnewswire.com - March 3 at 10:15 AMToronto Dominion Bank Buys 24,400 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - March 3 at 7:25 AMDecoding Regeneron Pharmaceuticals's Options Activity: What's the Big Picture?benzinga.com - March 1 at 2:31 PMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Mariner LLCmarketbeat.com - March 1 at 5:32 AMOptimistic Buy Rating for BridgeBio Pharma Amid Strong Market Position and Promising Treatment Pipelinemarkets.businessinsider.com - February 29 at 12:16 PMKarani Asset Management LLC Has $2.05 Million Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - February 28 at 6:02 PMAlnylam to Webcast Presentations at Upcoming March Investor Conferencesfinance.yahoo.com - February 27 at 10:43 AMAlnylam to Webcast Presentations at Upcoming March Investor Conferencesbusinesswire.com - February 27 at 8:30 AMNorthern Trust Corp Acquires 25,230 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - February 27 at 6:53 AMOMERS ADMINISTRATION Corp Takes $708,000 Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - February 25 at 9:38 AMEagle Asset Management Inc. Acquires 3,725 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - February 23 at 10:49 AMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Alnylam Pharma (ALNY) and Bausch Health Companies (BHC)markets.businessinsider.com - February 23 at 8:41 AMQ1 2024 Earnings Forecast for Alnylam Pharmaceuticals, Inc. Issued By HC Wainwright (NASDAQ:ALNY)marketbeat.com - February 23 at 7:17 AMAlnylam Pharmaceuticals, Inc. to Post FY2024 Earnings of ($4.19) Per Share, Chardan Capital Forecasts (NASDAQ:ALNY)marketbeat.com - February 22 at 7:50 AMAlnylam Pharmaceuticals, Inc.: Alnylam Earnings: Robust Uptake of Amvuttra Drives Sales; Shares Undervaluedfinance.yahoo.com - February 21 at 3:50 PMMarket Shifts: Upgrades and Downgrades Sweep Across Tech, Finance, and Healthcare Stocksmsn.com - February 21 at 10:48 AMKorea Investment CORP Lowers Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - February 21 at 6:51 AMCodexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Boardfinance.yahoo.com - February 20 at 8:46 AMAlnylam Pharmaceuticals’ New Regulation Risk – A Cause for Worry?msn.com - February 17 at 9:18 AMAlnylam Pharmaceuticals Full Year 2023 Earnings: In Line With Expectationsfinance.yahoo.com - February 17 at 9:18 AM Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below: Click Here To Get Your Free Copy ALNY Media Mentions By Week ALNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNY News Sentiment▼0.390.60▲Average Medical News Sentiment ALNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNY Articles This Week▼119▲ALNY Articles Average Week Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Royalty Pharma News BioMarin Pharmaceutical News United Therapeutics News Horizon Therapeutics Public News Ionis Pharmaceuticals News Madrigal Pharmaceuticals News Genmab A/S News BeiGene News Teva Pharmaceutical Industries News Viatris News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNY) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryUrgent: Protect Your Investments from a Chinese InvasionBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.